These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1481138)

  • 1. Involvement of the nigrotectal and nigrothalamic pathways in kappa opioid-induced circling.
    Thompson LA; Walker JM
    Synapse; 1992 Nov; 12(3):189-94. PubMed ID: 1481138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and ultrastructural neuroanatomy of interactive intratectal/tectonigral mesencephalic opioid inhibitory links and nigrotectal GABAergic pathways: involvement of GABAA and mu1-opioid receptors in the modulation of panic-like reactions elicited by electrical stimulation of the dorsal midbrain.
    Ribeiro SJ; Ciscato JG; de Oliveira R; de Oliveira RC; D'Angelo-Dias R; Carvalho AD; Felippotti TT; Rebouças EC; Castellan-Baldan L; Hoffmann A; Corrêa SA; Moreira JE; Coimbra NC
    J Chem Neuroanat; 2005 Dec; 30(4):184-200. PubMed ID: 16140499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical locomotor activating effects of kappa-opioid receptor stimulation in the preweanling rat: role of the ventromedial thalamus and superior colliculus.
    Zavala AR; Yoshida ST; Osburn JR; McDougall SA
    Brain Res Dev Brain Res; 2002 Dec; 139(2):301-6. PubMed ID: 12480145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of putative kappa opioid-sensitive cells of the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Prog Clin Biol Res; 1990; 328():335-8. PubMed ID: 2154790
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effects of the kappa opiate U50,488 in the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Brain Res; 1990 May; 517(1-2):81-7. PubMed ID: 2165438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
    Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
    Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic and functional neuroanatomical study of GABAergic disinhibitory striatum-nigral inputs and inhibitory nigrocollicular pathways: neural hodology recruiting the substantia nigra, pars reticulata, for the modulation of the neural activity in the inferior colliculus involved with panic-like emotions.
    Castellan-Baldan L; da Costa Kawasaki M; Ribeiro SJ; Calvo F; Corrêa VM; Coimbra NC
    J Chem Neuroanat; 2006 Aug; 32(1):1-27. PubMed ID: 16820278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dorsal striatal infusions of R(-)-propylnorapomorphine on kappa-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway.
    Charntikov S; Halladay LR; Herbert MS; Marquez EM; McDougall SA
    Neuroscience; 2008 Aug; 155(3):603-12. PubMed ID: 18616989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.
    Marin C; Bové J; Serrats J; Cortés R; Mengod G; Tolosa E
    Exp Neurol; 2005 Jan; 191(1):41-52. PubMed ID: 15589511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
    Gu B; Fraser MO; Thor KB; Dolber PC
    J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism.
    Kapusta DR; Obih JC
    J Pharmacol Exp Ther; 1995 Apr; 273(1):199-205. PubMed ID: 7714767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of striatonigral disinhibitory and nigrotectal inhibitory GABAergic pathways during the organization of defensive behavior by mice in a dangerous environment with the venomous snake Bothrops alternatus (Reptilia, Viperidae).
    Almada RC; Coimbra NC
    Synapse; 2015 Jun; 69(6):299-313. PubMed ID: 25727065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat.
    Kilpatrick IC; Collingridge GL; Starr MS
    Neuroscience; 1982 Jan; 7(1):207-22. PubMed ID: 7078726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.